Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

UPC Weekly - Doctrine of equivalence gets another airing at the UPC

UPC Weekly - Doctrine of equivalence gets another airing at the UPC

by Matthew Naylor

2025 Week 37 Various divisions of the UPC have been notably reluctant to set out their vision for a structured test for how infringement by equivalence should be assessed. Except the Local Division ...

Most Active Defendants in EPO Oppositions – 2024

Most Active Defendants in EPO Oppositions – 2024

by Katherine Green

Each year the European Patent Office (EPO) grants about 100,000 patents. Of these about 2-3% are opposed – meaning that a third party has formally filed a request that the EPO revoke the patent. This ...

Patent Strategies for Cell-based Therapeutics

Patent Strategies for Cell-based Therapeutics

by Nick Sutcliffe

Securing robust patent protection for cell-based therapeutics presents unique challenges, particularly before the European Patent Office (EPO). As the field of regenerative medicine and cell therapy ...

Mitochondria: the secret to regenerating human tissue?

Mitochondria: the secret to regenerating human tissue?

by Eliot Ward

Istesso co-founder Lisa Patel is researching how to regenerate and repair tissue by modulating mitochondria. The method has the potential to treat multiple diseases of ageing, such as arthritis, ...

Bispecific antibodies: A new way to combat drug resistance

Bispecific antibodies: A new way to combat drug resistance

by Tanis Keirstead

Biotech veteran Dr Rob Arathoon is pioneering a new way to counteract multi-drug resistance in cancer using bispecific antibodies. He explains his work.

Ozempic and the Anti-Ageing Opportunity

Ozempic and the Anti-Ageing Opportunity

by Katherine Collins

Semaglutide, a GLP-1 receptor agonist (GLP-1RA) best known by its brand names Ozempic and Wegovy, has already reshaped the treatment landscape for type 2 diabetes and obesity. However, compelling new ...

Forward Magazines 4

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.